Involvement of PI3K/AKT/GSK3beta pathway in tetrandrine-induced G1 arrest and apoptosis

Xuan-li Chen1, Kai-huan Ren, Hong-wei He

  • 1Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Insights

Tetrandrine triggers cancer cell death by halting the cell cycle and inducing apoptosis. This study reveals the phosphoinositide 3-kinase/AKT/glycogen synthase kinase-3 beta (PI3K/AKT/GSK3β) pathway is crucial for these effects.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Tetrandrine is known to induce cell cycle arrest and apoptosis in human cancer cells.
  • The PI3K/AKT/GSK3β signaling pathway plays a critical role in cell proliferation, survival, and apoptosis.

Purpose of the Study:

  • To investigate the role of the PI3K/AKT/GSK3β pathway in tetrandrine-induced G1 arrest and apoptosis.
  • To elucidate the molecular mechanisms underlying tetrandrine's anti-cancer effects.

Main Methods:

  • Utilized HT-29 human colon cancer cells.
  • Analyzed protein expression and phosphorylation levels (AKT, GSK3β, p27kip1, cyclin D1).
  • Assessed apoptosis markers (caspase 3, PARP cleavage) and cell cycle progression.
  • Employed selective GSK3β inhibitors and small interfering RNA (siRNA) for GSK3β knockdown.
  • Transfected cells with wild-type GSK3β.

Main Results:

  • Tetrandrine induced AKT dephosphorylation and GSK3β activation/nuclear translocation in HT-29 cells.
  • Tetrandrine upregulated p27kip1, leading to cyclin D1 phosphorylation and proteolysis.
  • GSK3β activation by tetrandrine promoted caspase 3 activation and PARP cleavage, key events in apoptosis.
  • Inhibition or knockdown of GSK3β attenuated tetrandrine-induced G1 arrest and apoptosis.
  • Overexpression of GSK3β mimicked tetrandrine's effects, inducing G1 arrest and apoptosis.

Conclusions:

  • Tetrandrine induces G1 cell cycle arrest and apoptosis in human cancer cells via the PI3K/AKT/GSK3β signaling pathway.
  • GSK3β acts as a critical mediator in the anti-cancer effects of tetrandrine.
  • Targeting GSK3β may represent a therapeutic strategy for cancer treatment.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...